key: cord-0813202-uir3i8xa authors: Yu, Cheng-Jun; Wang, Zi-Xiao; Xu, Yue; Hu, Ming-Xia; Chen, Kai; Qin, Gang title: Assessment of basic reproductive number for COVID-19 at global level: A meta-analysis date: 2021-05-07 journal: Medicine (Baltimore) DOI: 10.1097/md.0000000000025837 sha: e9a0ca91eaf36239f69fe1baffaf050f64532e69 doc_id: 813202 cord_uid: uir3i8xa BACKGROUND: There are large knowledge gaps regarding how transmission of 2019 novel coronavirus disease (COVID-19) occurred in different settings across the world. This study aims to summarize basic reproduction number (R(0)) data and provide clues for designing prevention and control measures. METHODS: Several databases and preprint platforms were retrieved for literature reporting R(0) values of COVID-19. The analysis was stratified by the prespecified modeling method to make the R(0) values comparable, and by country/region to explore whether R(0) estimates differed across the world. The average R(0) values were pooled using a random-effects model. RESULTS: We identified 185 unique articles, yielding 43 articles for analysis. The selected studies covered 5 countries from Asia, 5 countries from Europe, 12 countries from Africa, and 1 from North America, South America, and Australia each. Exponential growth rate model was most favored by researchers. The pooled global R(0) was 4.08 (95% CI, 3.09–5.39). The R(0) estimates for new and shifting epicenters were comparable or even higher than that for the original epicenter Wuhan, China. CONCLUSIONS: The high R(0) values suggest that an extraordinary combination of control measures is needed for halting COVID-19. In January 2020, the general public became aware of an outbreak of a novel coronavirus strain, now termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which had been affecting Wuhan city, China. The disease has been spreading rapidly worldwide, leading the World Health Organization (WHO) to declare a pandemic on March 11, 2020 . While majority of cases have been relatively mild outside of Wuhan, [1] a lot of uncertainties remain about the severity of the 2019 novel coronavirus disease (COVID-19) on a per-case basis. Further-more, higher-than-normal spread rates expected from this virus may result in population-level severe morbidity and mortality even if the case-fatality ratio remains low. There exist large knowledge gaps regarding how transmission of SARS-CoV-2 occurred in different settings across the world. The basic reproduction number (R 0 ) is one of the fundamental and most often used metrics that describes the contagiousness or transmissibility of the infectious agent at the beginning of an epidemic. The proportion of the population needed to be vaccinated for the elimination of an infection can be based on R 0 values. [2] Estimating R 0 is a requisite for designing prevention and control measures for infectious diseases such as COVID- 19 . Although many researchers estimated the reproductive number of COVID-19, their results, as well as stages of infection, measurement methods, and applied preventive interventions differ substantially across the studies. Considering the variability of the reproductive numbers among the countries, we attempt to summarize available R 0 estimates of COVID-19 at the global level. The pooled statistical findings might help to characterize the spread of the disease and inform public health policy. Our study conforms to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. [3] We retrieved literature from the PubMed, EmBase, China National Knowledge Infrastructure (Chinese), WanFang (Chinese) database, and BioRxiv, MedRxiv, arXiv preprint platforms in August, 2020. The search terms included: ("novel coronavirus" or "SARS-CoV-2" or "2019 novel coronavirus disease" or "COVID-19") and ("basic reproduction number" or "R 0 " or "transmission" or "epidemic dynamics"). To identify additional studies, we reviewed and hand searched the references of important articles. Two independent authors screened the titles and abstracts for relevance. Articles were evaluated for inclusion according to the following criteria: described the early epidemic dynamics of COVID-19 in the country or region; reported basic reproduction number based on daily data of COVID-19 case counts; and presented in English or Chinese language. Nonhuman and laboratory studies were excluded, as well as studies merely reporting time-dependent reproductive number. No exclusions were made for modeling methods used for R 0 estimation. The name of the first author, country or region, estimation period, measurement method, the estimated R 0 value (with certain confidence interval [CI]) and digital object identifier were extracted from the articles. All studies that estimated R 0 for COVID-19 were used for systemic review, while only those with 95% CI were entered into the meta-analysis. We stratified the analysis by prespecified modeling method to make the R 0 values comparable, and by country/region to examine if R 0 estimates differed across the world. The average R 0 values were pooled using a random-effects model. The I 2 values were used for heterogeneity evaluation. A threshold of I 2 ≥ 50% indicated high heterogeneity. Publication bias was assessed with Begg and Egger tests, as well as the funnel plots visually. Moreover, sensitivity analysis was performed using a 1-studyremoved analysis. All statistical analyses were conducted using Stata software (version 15.0, StataCorp, TX, USA). Statistical significance was defined as a P value < .05. The map was performed using ArcGIS software (version 10.6, Esri, USA). Our database search led to 413 studies, 228 of which were duplicates, and 72 of which were deemed irrelevant based on review of their titles and abstracts. Of the remaining 113 studies, 32 did not report the reproduction number, 21 reported effective reproduction number (Re) or real-time reproduction number (Rt) rather than R 0 , 9 lacked data source and 8 lacked methodology for estimation. Finally, a total of 43 studies were included for the analysis (Fig. 1 ). From the 43 studies (Tables 1 and 2) , 61 estimates of R 0 values were exacted, majority (39) of which were for China (including for Wuhan city specifically). The remaining estimates were presented for Korea (6), United States (3), Italy (2), Iran (2), followed by Japan (1), India (1), The United Kingdom (1), France (1), Germany (1), Spain (1), Brazil (1), Australia (1), and top 12 countries in Africa (1). As shown in Table 1 , the evaluation techniques or models for R 0 estimation were diverse. Exponential growth rate (EGR) model, [10] China January 15-31, 2020 SEIR 3.91 3.71-4.11 Tang B [16] China By January 22, 2020 SEIR 6.47 5.71-7.23 Zhou T [17] China By 25 January, 2020 SEIR 2.80-3.30 (3.05) / Zhou WK [18] China By January 10, 2020 SEIR 5.32 / Cao ZD [19] China By January 23, 2020 SEIRDC 4.08 Chen TM [20] Wuhan December 7, 2019 to January 1, 2020 SEIAR 3.58 / LI Y [21] China By January 23, 2020 SEIQR 5.60 / Li JH [7] Wuhan January 10-23, 2020 MLE 2.65 2.64-2.67 Song QQ [10] China January 15-31, 2020 MLE 3.16 2.90-3.43 Tang B [22] China January 1-23, 2020 MLE 3.80 3.50-4.20 Tang B [22] Guangdong January 19-31, 2020 MLE 3.00 2.60-3.30 Wang Y [5] China January 17 to February 8, 2020 MLE 2.99 2.93-3.06 Jung SM [23] China By January 24, 2020 Epidemic growth model 2.10 2.00-2.20 Jung SM [23] China By January 24, 2020 Epidemic growth model 3.20 2.70-3.70 Li JH [7] Wuhan January 10-23, 2020 Sequential Bayesian method 1.68 1.09-2.33 Wang Y [5] China ) CI = confidence interval, EGR = exponential growth rate, GLEAM = global epidemic and mobility model, HDI = high-density interval, MLE = maximum likelihood estimation, SEIAR = susceptible, exposed symptomatic, infectious asymptomatic, infectious removed, SEIQR = susceptible, exposed, infected but not hospitalized, infectious and isolated recovered, SEIR = susceptible-exposed-infected-removed, SEIRDC = SEIR with death cumulative, SLIR = susceptible latent infectious recovered. 1 and 2 ). As shown in Figure 2 , the R 0 estimates were conducted for 6 continents, Asia (5 countries), Europe (5 countries), Africa (12 countries), Australia (1 country), North America (1 country), and South America (1 country). The map represented individual R 0 estimate for 12 countries, and a single R 0 for Africa covering 12 countries, which was a study at a regional scale. [4] The highest country-level R 0 estimates are for France (R 0 , 6.32; 95% CI, 5.72-6.99), following Germany (R 0 , 6.07; 95% CI, 5.51-6.69) and Spain (R 0 , 5.08; 95% CI, 4.51-5.74). The R 0 for Wuhan city, China and New York state, USA were 4.47 (95% CI 3.10-6.44) and 6.40 (95% CI, 4.30-9.00) respectively. [35] France February 23 to March 9, 2020 EGR 6.32 5.72-6.99 Yuan J [35] Germany February 21 to March 9, 2020 EGR 6.07 5.51-6.69 Yuan J [35] Italy February 23 to March 9, 2020 EGR 3.27 3.17-3.38 Yuan J [35] Spain February 19 to March 9, 2020 EGR 5.08 4.51-5.74 Choi S [36] Korea January 20 to February 17, 2020 SEIR 0.56 0.51-0.60 Dropkin G [37] United Kingdom January 30 to March 31, 2020 SEIR 6.94 6.52-7.39 Kuniya T [38] Japan January 15 to February 29, 2020 SEIR 2.60 2.40-2.80 D'Arienzo M [39] Italy January 25 to March 12, 2020 SIR 2.43-3.10 / Khosravi A [40] Iran [45] Australia January 21 to March 28, 2020 Agent-based model 2.27 / Ives AR [46] New York state, USA February 26 to April 20, 2020 Time-varying autoregressive state-space model 6.40 4.30-9.00 CI = confidence interval, EGR = exponential growth rate, MLE = maximum likelihood estimation, SEIR = susceptible-exposed-infected-removed, SIR = susceptible-infected-removed. After pooling the 5 R 0 estimates based on EGR models, we got the average R 0 as 4.47 (95% CI, 3.10-6.44, I 2 = 99.5%) for Wuhan. The pooled R 0 for China was estimated as 3.83 (95% CI, 3.30-4.44; I 2 = 98.8%). Moreover, combining the pooled result for China and EGR model-based estimates for other 7 countries or regions, we obtained the pooled global R 0 for COVID-19 was 3.42 (95% CI, 2.59-4.51; I 2 = 98.6%). If the R 0 estimate for Korea based on data collected before its exponential growth is excluded, the pooled global R 0 may be 4.08 (95% CI 3.09-5.39) (Fig. 3) . www.md-journal.com SEIR models have been used for R 0 estimates for China, Japan, and Korea. The pooled R 0 for China was estimated as 4.50 (95% CI, 3.71-5.46; I 2 = 96.1%). The pooled Asian R 0 was 3.50 (95% CI, 1.64-5.36; I 2 = 99.8%) from the meta-analysis (see Figure s1 , Supplemental Content, which illustrates the forest plot of the pooled SEIR model-based R0 estimates, http://links.lww.com/ MD2/A141). Meanwhile, MLE models have also been applied to estimate R 0 for China, Korea, and Iran. The pooled R 0 for China was estimated as 3.28 (95% CI, 2.87-3.76, I 2 = 92.3%). The pooled Asian R 0 estimate was 2.85 (95% CI, 2.41-3.37; I 2 = 81.1%) (see Figure s2 , Supplemental Content, which illustrates the forest plot of the pooled MLE model-based R 0 estimates, http://links.lww.com/MD2/A142). The sensitivity analysis showed that no individual study significantly affected the summarized results of R 0 (see Knowledge of the basic reproductive number is critical for understanding the dynamics of the novel coronavirus disease. As the pandemic progresses in space and time, this needs to be reevaluated. To the best of our knowledge, this study for the first time summarized the R 0 values at the global level. This study might help to characterize the spread scale of the disease, and convey a clear message to public health decision makers. R 0 is affected by lots of biosocial factors and is estimated by various complex mathematical models. Therefore, the R 0 values are usually dependent on model structures and assumptions. It is recommended not to compare values based on different models. [2] Based on this review, the EGR model was the most common method addressed by the available studies. It has been more than 3 decades since the development of EGR model which embraces both the infection cycle and the change in number of new case counts within the Lotka-Euler framework. [47] By comparing 4 methods, Wang et al [5] found that EGR model fitted the Chinese COVID-19 data best. Our study calculated pooled R 0 values with the same method respectively, avoiding the limitation of different modeling. Through this approach we got more comparable estimates than previous meta-analyses. [48] Using the assumption of exponential growth (EGR models), we found R0 values of 4.54 (95% CI 3.18-5.90) and 3.69 (95% CI 3.17-4.21) for Wuhan and China respectively. Compared with severe acute respiratory syndrome (SARS, R 0 = 3, range 2.2-3.6) and Middle East respiratory syndrome (R 0 range 0.8-1.3), [49, 50] COVID-19 has a higher R 0 , suggesting the novel coronavirus be more contagious and stringent public health strategies be necessary. One modeling study indicated that if R 0 were above 3.5, even near perfect case isolation and contact tracing would not be sufficient to control COVID-19 outbreaks. [51] Lessons from influenza pandemics also tell us that timely implementation of nonpharmaceutical interventions (NPIs), including infection control, social distancing, small area lockdown, and travel restrictions, is warranted. [52] It is on January 30, 2020 that the WHO declared the COVID-19 a public health emergency of international concern, 1 week after Chinese government launched the unprecedented lockdown in Wuhan epicenter and other 12 cities in Hubei province. Significant decrease in the growth rate of COVID-19 cases within China was reported by us and other researchers. [53, 54] In contrast, new epicenters were developing and shifting across the world during the same period. Some epidemiological parameters in countries except China could be different based on control strategies. However, it is clear that the R 0 values for United States, France, Germany, Italy, and Spain from February to March were comparable or even higher than that of Wuhan. Africa, the last continent to be hit by the COVID-19 pandemic, is expected to be the most vulnerable continent. Interestingly, most of the identified COVID-19 cases in Africa had been imported from Europe and the United States, rather than from the original COVID-19 epicenter China. [55] Maybe, this situation would have been different if the alert call from WHO and the NPI example from China were taken into consideration on time by these authorities. [56] It is worth noting that some estimates of R 0 were significantly lower for Korea than those for most other countries. The previous 2 studies reporting subexponential growth dynamic in Korea used data collected before February 17, 2020. However, it was on February 19, 2020 when the number of confirmed COVID-19 cases started to increase rapidly. The increased spread of COVID-19 in Korea may be attributed to one superspreading event that had resulted in more than 3900 secondary cases stemming from church services in the city of Daegu. [6] Admittedly, there are several limitations in this study. First, the study covered a small number of world countries and was not enough to cover the geographical dimensions of the continents. Second, the study did not assess meteorological characteristics of a location and demographic characteristics of that location's population which might influence the disease transmission pattern. Last, some articles included for analysis are preprints that might affect the overall quality of the review to some extent. In conclusion, the relatively high value for R 0 suggests that an extraordinary combination of control measures is needed for halting COVID-19. Indeed, at the expected transmissibility of the pandemic pathogen, timely NPIs should be implemented before a highly efficacious vaccine could become available. Such efforts will be the key to quell local outbreaks and reduce the risk of further global dissemination. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Complexity of the Basic Reproduction Number (R0) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa Estimating the basic reproduction number of COVID-19 in Wuhan, China Transmission potential and severity of COVID-19 in South Korea Estimation of the epidemic properties of the 2019 novel coronavirus: a mathematical modeling study. medRxiv 2020;preprint Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China. bioRxiv 2020;preprint High contagiousness and rapid spread of severe acute respiratory syndrome Coronavirus 2 Study on assessing early epidemiological parameters of coronavirus disease epidemic in China Analysis of the epidemic growth of the early 2019-nCoV outbreak using internationally confirmed cases. medRxiv 2020;preprint Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) cases in China in the First Half of January 2020: a data-driven modelling analysis of the early outbreak Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv 2020;preprint Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak Estimating the effective reproduction number of the 2019-nCoV in China. medRxiv 2020;preprint A mathematical model for simulating the phase-based transmissibility of a novel coronavirus Basic reproduction number and predicted trends of coronavirus disease 2019 epidemic in the mainland of China Lessons drawn from China and South Korea for managing COVID-19 epidemic: insights from a comparative modeling study Real time estimation of the risk of death from novel coronavirus (2019-nCoV) infection: Inference using exported cases Incorporating human movement data to improve epidemiological estimates for 2019-nCoV The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak Early transmission dynamics in Wuhan, China, of Novel coronavirus-infected pneumonia Risk for transportation of 2019 Novel Coronavirus (COVID-19) from Wuhan to Cities in China. medRxiv 2020;preprint . Imperial College London COVID-19 Response Team Early transmissibility assessment of a novel coronavirus in Wuhan Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Pattern of early human-to-human transmission of Wuhan 2019-nCoV Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil Assessing the impact of complete lockdown on COVID-19 Infections in India and its burden on public health facilities Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Republic of Korea Monitoring transmissibility and mortality of COVID-19 in Europe Estimating the reproductive number and the outbreak size of COVID-19 in Korea COVID-19 UK Lockdown Forecasts and R0 Prediction of the epidemic peak of coronavirus disease in Japan, 2020 Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud Transmission potential of COVID-19 in Iran The COVID-19 Pandemic, Community Mobility and the Effectiveness of Non-pharmaceutical interventions: The United States of America Time-Varying COVID-19 Reproduction Number in the United States Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea from 31 Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling State-by-state estimates of R0 at the start of COVID-19 outbreaks in the USA How generation intervals shape the relationship between growth rates and reproductive numbers Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: meta-analysis and sensitivity analysis Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility Transmission dynamics and control of severe acute respiratory syndrome Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Modeling targeted layered containment of an influenza pandemic in the United States Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi City, China: early epidemiological findings The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China Africa braces for coronavirus, but slowly. The New York Times Is the Cure Worse than the Disease? County-Level Evidence from the COVID-19 Pandemic in the United States The authors thank Prof Lei Zhang from Xi'an Jiaotong University Health Science Center for his valuable scientific comments and advices. GQ designed the study protocol. CJY, ZXW, and YX did the literature search. The titles, abstracts, and full texts were screened and selected by CJY and MXH. The data were extracted and analysed by CJY, MXH and KC. CJY, ZXW, and YX drafted the manuscript. GQ edited the draft. All authors read and approved the final manuscript.Yu et al. 100: 18 Medicine